libbyshope.com
Ampligen® To Be Tested In Phase I/II Study In Tandem With UPenn Ovarian Cancer Vaccine
Hemispherx Biopharma’s Ampligen® is being tested in combination with an experimental ovarian cancer vaccine developed by the Penn Ovarian Cancer Research Center. Hemispherx Biopharma, Inc. (“Hemisp…